Lonza expands manufacturing collaboration for Altimmune COVID-19 vaccine candidate

MOSCOW (MRC) -- Lonza says it has expanded its manufacturing collaboration with Altimmune (Gaithersburg, Maryland), a clinical-stage biopharmaceutical company, for Altimmune's single-dose intranasal COVID-19 vaccine candidate, AdCOVID, said Chemweek.Lonza will commission a dedicated manufacturing suite for clinical and commercial production of AdCOVID, at its facility near Houston, Texas,

Full article at mrcplast.com